Literature DB >> 26782245

The βLys66Tyr Variant of Human Hemoglobin as a Component of a Blood Substitute.

R S Silkstone1, G Silkstone1, J A Baath2, B Rajagopal1, P Nicholls1, B J Reeder1, L Ronda3, L Bulow2, C E Cooper4.   

Abstract

It has been proposed that introducing tyrosine residues into human hemoglobin (e.g. βPhe41Tyr) may be able to reduce the toxicity of the ferryl heme species in extracellular hemoglobin-based oxygen carriers (HBOC) by facilitating long-range electron transfer from endogenous and exogenous antioxidants. Surface-exposed residues lying close to the solvent exposed heme edge may be good candidates for mutations. We therefore studied the properties of the βLys66Tyr mutation. Hydrogen peroxide (H2O2) was added to generate the ferryl protein. The ferryl state in βLys66Tyr was more rapidly reduced to ferric (met) by ascorbate than recombinant wild type (rwt) or βPhe41Tyr. However, βLys66Tyr suffered more heme and globin damage following H2O2 addition as measured by UV/visible spectroscopy and HPLC analysis. βLys66Tyr differed notably from the rwt protein in other ways. In the ferrous state the βLys66Tyr forms oxy, CO, and NO bound heme complexes similar to rwt. However, the kinetics of CO binding to the mutant was faster than rwt, suggesting a more open heme crevice. In the ferric (met) form the typical met Hb acid-alkaline transition (H2O to -OH) appeared absent in the mutant protein. A biphasicity of cyanide binding was also evident. Expression in E. coli of the βLys66Tyr mutant was lower than the rwt protein, and purification included significant protein heterogeneity. Whilst, βLys66Tyr and rwt autoxidised (oxy to met) at similar rates, the oxygen p50 for βLys66Tyr was very low. Therefore, despite the apparent introduction of a new electron transfer pathway in the βLys66Tyr mutant, the heterogeneity, and susceptibility to oxidative damage argue against this mutant as a suitable starting material for a HBOC.

Entities:  

Keywords:  Blood substitute; HBOC; Hemoglobin; Mutation; Oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 26782245     DOI: 10.1007/978-1-4939-3023-4_57

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Current Challenges in the Development of Acellular Hemoglobin Oxygen Carriers by Protein Engineering.

Authors:  Andres S Benitez Cardenas; Premila P Samuel; John S Olson
Journal:  Shock       Date:  2019-10       Impact factor: 3.454

2.  Engineering tyrosine electron transfer pathways decreases oxidative toxicity in hemoglobin: implications for blood substitute design.

Authors:  Gary G A Silkstone; Rebecca S Silkstone; Michael T Wilson; Michelle Simons; Leif Bülow; Kristian Kallberg; Khuanpiroon Ratanasopa; Luca Ronda; Andrea Mozzarelli; Brandon J Reeder; Chris E Cooper
Journal:  Biochem J       Date:  2016-07-28       Impact factor: 3.857

Review 3.  The peroxidatic activities of Myoglobin and Hemoglobin, their pathological consequences and possible medical interventions.

Authors:  Michael T Wilson; Brandon J Reeder
Journal:  Mol Aspects Med       Date:  2021-10-13

4.  Oxidative Implications of Substituting a Conserved Cysteine Residue in Sugar Beet Phytoglobin BvPgb 1.2.

Authors:  Simon Christensen; Leonard Groth; Nélida Leiva-Eriksson; Maria Nyblom; Leif Bülow
Journal:  Antioxidants (Basel)       Date:  2022-08-20

5.  Engineering tyrosine residues into hemoglobin enhances heme reduction, decreases oxidative stress and increases vascular retention of a hemoglobin based blood substitute.

Authors:  Chris E Cooper; Gary G A Silkstone; Michelle Simons; Badri Rajagopal; Natalie Syrett; Thoufieq Shaik; Svetlana Gretton; Elizabeth Welbourn; Leif Bülow; Nélida Leiva Eriksson; Luca Ronda; Andrea Mozzarelli; Andras Eke; Domokos Mathe; Brandon J Reeder
Journal:  Free Radic Biol Med       Date:  2018-12-27       Impact factor: 7.376

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.